ISG revenues soar to new heights
Sales of diagnostic imaging software to several large medical-device customers and a rise in licensing fees helped boost fourth-quarter and year-end financials to record levels for ISG Technologies. The Toronto-based medical-imaging software developer
Sales of diagnostic imaging software to several large medical-device customers and a rise in licensing fees helped boost fourth-quarter and year-end financials to record levels for ISG Technologies. The Toronto-based medical-imaging software developer reported a 30% increase in revenues and a 250% increase in earnings for its fiscal year (end-June 30). Revenues were $32 million (U.S.) in fiscal 1999, up from $24.3 million in fiscal 1998. The company had earnings of $1.2 million, compared with $336,500 last year. Revenues for the quarter were $9.8 million, compared with $6.8 million for the fourth quarter a year ago. Profits for the quarter were $608,000, compared with $135,000 for the same period in 1998.
ISG realized earnings increases in all three of its business units (image management, diagnostic imaging, and image-guided surgery), plus a 62% rise in software license fee generation, according to CEO Michael Greenberg. The enhanced penetration of ISGs Image Application Platform software in healthcare accounts for the increase in licensing fees, according to ISG.
ASCO: Study Reveals Significant Racial/Ethnic Disparities with PSMA PET Use for Patients with mPCa
May 30th 2025Latinx patients with metastatic prostate cancer were 63 percent less likely than non-Hispanic White patients to have PSMA PET scans, according to a study of 550 patients presented at the American Society of Clinical Oncology (ASCO) conference.
Lunit Unveils Enhanced AI-Powered CXR Software Update
May 28th 2025The Lunit Insight CXR4 update reportedly offers new features such as current-prior comparison of chest X-rays (CXRs), acute bone fracture detection and a 99.5 percent negative predictive value (NPV) for identifying normal CXRs.
New MRI Study Questions Use of Corticosteroid Injections for Knee OA
May 27th 2025Two years after intraarticular knee injections for knee osteoarthritis (OA), study participants who had corticosteroid knee injections had greater OA progression than control patients while the use of hyaluronic acid injections was associated with less OA progression.
